Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial

Trials. 2021 Mar 5;22(1):187. doi: 10.1186/s13063-021-05153-4.

Authors

Iwein Gyselinck¹, Laurens Liesenborghs², Ewout Landeloos², Ann Belmans³, Geert Verbeke³, Peter Verhamme², Robin Vos², W Janssens²; DAWn-Azithro consortium

Affiliations

¹ Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium. [email protected].
² Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
³ Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.

No abstract available

Publication types

Published Erratum